Medication enhancement using hydrogen
Embodiments described herein generally relate to medicinal compositions (e.g., compositions comprising an active pharmaceutical agent) such as those comprising liquid hydrogen and/or hydrogen gas. In certain embodiments, the composition comprises hydrogen and/or noble gas(es) in a medicinal composition, for example, within the aqueous phase (e.g., dissolved). For example, in some cases, the medicinal composition may comprise an active pharmaceutical ingredient and hydrogen (H 2 ) and/or noble gas(es). The noble gas may be, for example, xenon, argon, or the like. In some embodiments, the hydrogen and/or the noble gas(es) may infuse with the composition (e.g., such that at least a portion of the hydrogen gas and/or noble gas(es) is dissolved within the composition). Such compositions comprising hydrogen gas and/or noble gas(es) may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like. Such compositions and/or liquids described herein may be administered (e.g., orally, intravenously, inhaled) to/by a subject.
1. An article, comprising:
a sealed container containing an aqueous solution comprising (a) dissolved H 2 at a concentration of at least 1 ppm by mass, and (b) one or more cannabinoids selected from the group consisting of tetrahydrocannabinol and cannabidiol.
2. The article of claim 1 , wherein the container has an internal pressure of at least 1 psi greater than atmospheric pressure.
3. The article of claim 1 , wherein the aqueous solution comprises dissolved H 2 at a concentration of at least 3 ppm.
4. The article of claim 1 , wherein the aqueous solution comprises tetrahydrocannabinol.
5. The article of claim 1 , wherein the aqueous solution comprises cannabidiol.
6. The article of claim 1 , wherein the one or more cannabinoids are present at at least 1 wt % of the solution.
7. The article of claim 1 , wherein the aqueous solution further comprises flavoring.
8. The article of claim 1 , wherein the aqueous solution comprises at least 90% water by mass.
9. The article of claim 1 , wherein the container is a can.
10. The article of claim 1 , wherein the container is an aluminum can.
11. The article of claim 1 , wherein the container is a bottle.
12. A method, comprising:
unsealing a sealed container containing an aqueous solution comprising (a) dissolved H 2 at a concentration of at least 1 ppm by mass, and (b) one or more cannabinoids selected from the group consisting of tetrahydrocannabinol and cannabidiol; and
drinking the aqueous solution.
13. The method of claim 12 , wherein the sealed container has an internal pressure of at least 1 psi greater than atmospheric pressure.
14. The method of claim 12 , wherein the aqueous solution comprises dissolved H 2 at a concentration of at least 3 ppm.
15. The method of claim 12 , wherein the aqueous solution comprises tetrahydrocannabinol.
16. The method of claim 12 , wherein the aqueous solution comprises cannabidiol.
17. The method of claim 12 , wherein the one or more cannabinoids are present at at least 1 wt % of the solution.
18. The method of claim 12 , wherein the aqueous solution comprises at least 90% water by mass.
19. The method of claim 12 , wherein the container is a can.
20. The method of claim 12 , wherein the container is a bottle.